Fidelity Investments’s Zosano Pharma Corporation ZSAN Stock Holding History

Fidelity Investments’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Hold	0	–	–	–	5316
2021 Q2	–	Hold	0	–	–	–	5143
2017 Q4	–	Sell	-2,460	Closed	-$1.42M	–	2727
2017 Q3	$1.42M	Sell	2,460 -77	-3%	-$56.5K	﹤0.01%	2376
2017 Q2	$2.5M	Hold	2,537	–	–	﹤0.01%	2310
2017 Q1	$3.37M	Hold	2,537	–	–	﹤0.01%	2240
2016 Q4	$1.39M	Hold	2,537	–	–	﹤0.01%	2428
2016 Q3	$1.35M	Hold	2,537	–	–	﹤0.01%	2420
2016 Q2	$2.34M	Sell	2,537 -20	-0.8%	-$25.8K	﹤0.01%	2353
2016 Q1	$4.12M	Sell	2,557 -7	-0.3%	-$11.5K	﹤0.01%	2214
2015 Q4	$4M	Buy	2,564 +1,135	+79%	+$2.21M	﹤0.01%	2257
2015 Q3	$3.96M	Hold	1,429	–	–	﹤0.01%	2244
2015 Q2	$7.25M	Hold	1,429	–	–	﹤0.01%	2138
2015 Q1	$10.1M	Buy	+1,429	New	+$10.7M	﹤0.01%	1990

Other funds holding ZSAN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Fidelity Investments's ZSAN Position: Q3 2021 in Review

Fidelity Investments held its Zosano Pharma Corporation (ZSAN) position steady in Q3 2021 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5316.

Fidelity Investments first reported a position in ZSAN in Q1 2015 and has held it in 11 quarters since. The position peaked at $10.1M in Q1 2015. 32 funds tracked by Wall St. Rank hold ZSAN as of Q3 2021.

Fidelity Investments held 0 shares of Zosano Pharma Corporation worth $0 as of Q3 2021.
Fidelity Investments left its Zosano Pharma Corporation share count unchanged in Q3 2021.
Zosano Pharma Corporation made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2021, its #5316 holding.
Fidelity Investments first reported a position in Zosano Pharma Corporation in Q1 2015 and has held it in 11 quarters since.
Fidelity Investments's Zosano Pharma Corporation position peaked at $10.1M in Q1 2015.
32 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q3 2021.

Based on Fidelity Investments's 13F filing for Q3 2021, filed 15 Nov 2021.